SCHEMBL17152214

SCHEMBL17152214

NCCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccc(O)cc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 16/20 0.81
▸ ESR1 P03372 14/20 0.81
▸ ESR2 Q92731 13/20 0.81
▸ CYP3A4 P08684 3/20 0.67
▸ CYP1A2 P05177 2/20 0.67
▸ CYP2A6 P11509 2/20 0.67
▸ CYP3A5 P20815 2/20 0.67
▸ CYP2D6 P10635 2/20 0.58
▸ EBP Q15125 2/20 0.58
▸ SIGMAR1 Q99720 2/20 0.58
▸ IDH1 O75874 1/20 0.58
▸ KCNH2 Q12809 1/20 0.58
▸ EGFR P00533 1/20 0.58
▸ ERBB2 P04626 1/20 0.58
▸ FYN P06241 1/20 0.58
▸ CHRM2 P08172 1/20 0.58
▸ CHRM4 P08173 1/20 0.58
▸ CHRM5 P08912 1/20 0.58
▸ ADRA2A P08913 1/20 0.58
▸ ADORA3 P0DMS8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17470686 0.94 CYP19A1 (0.69) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL8642207 0.86 ESR1 (0.58) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL8770194 0.86 ESR1 (0.58) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL22995790 0.81 CYP19A1 (1.00) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL28404807 0.81 CYP19A1 (1.00) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL24302096 0.81 CYP19A1 (1.00) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL10379044 0.81 ESR1 (1.00) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL18284450 0.81 ESR1 (1.00) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL10108163 0.81 ESR1 (1.00) CYP19A1ESR1ESR2CYP3A4CYP1A2
SCHEMBL8612298 0.80 ESR1 (0.64) ESR1ESR2CYP3A4CYP2D6EBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9687458-B2 Trans-clomiphene for use in cancer therapy REPROS THERAPEUTICS INC. (US) 2017-06-27 — — US disclosed
US-9616034-B2 Trans-clomiphene and its analogues as agents that increase bone mineral density REPROS THERAPEUTICS INC. (US) 2017-04-11 — — US disclosed
US-20160128953-A1 TRANS-CLOMIPHENE AND ITS ANALOGUES AS AGENTS THAT INCREASE BONE MINERAL DENSITY REPROS THERAPEUTICS INC. (US) 2016-05-12 — — US disclosed
US-20150283099-A1 Trans-Clomiphene for Use in Cancer Therapy REPROS THERAPEUTICS INC. (US) 2015-10-08 — — US disclosed
Send feedback